594 related articles for article (PubMed ID: 16344523)
1. Plasma cells in muscle in inclusion body myositis and polymyositis.
Greenberg SA; Bradshaw EM; Pinkus JL; Pinkus GS; Burleson T; Due B; Bregoli L; O'Connor KC; Amato AA
Neurology; 2005 Dec; 65(11):1782-7. PubMed ID: 16344523
[TBL] [Abstract][Full Text] [Related]
2. Myeloid dendritic cells in inclusion-body myositis and polymyositis.
Greenberg SA; Pinkus GS; Amato AA; Pinkus JL
Muscle Nerve; 2007 Jan; 35(1):17-23. PubMed ID: 16969836
[TBL] [Abstract][Full Text] [Related]
3. Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM.
Chahin N; Engel AG
Neurology; 2008 Feb; 70(6):418-24. PubMed ID: 17881720
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis.
Cherin P; Herson S; Crevon MC; Hauw JJ; Cervera P; Galanaud P; Emilie D
J Rheumatol; 1996 Jul; 23(7):1135-42. PubMed ID: 8823683
[TBL] [Abstract][Full Text] [Related]
5. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis.
Dimitri D; Benveniste O; Dubourg O; Maisonobe T; Eymard B; Amoura Z; Jean L; Tiev K; Piette JC; Klatzmann D; Herson S; Boyer O
Brain; 2006 Apr; 129(Pt 4):986-95. PubMed ID: 16455793
[TBL] [Abstract][Full Text] [Related]
6. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
Schmidt J; Rakocevic G; Raju R; Dalakas MC
Brain; 2004 May; 127(Pt 5):1182-90. PubMed ID: 15047591
[TBL] [Abstract][Full Text] [Related]
7. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
Figarella-Branger D; Schleinitz N; Boutière-Albanèse B; Camoin L; Bardin N; Guis S; Pouget J; Cognet C; Pellissier JF; Dignat-George F
J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117
[TBL] [Abstract][Full Text] [Related]
8. Polymyositis: not a unicorn or mythological beast...but maybe a duck?
Kissel JT
Neurology; 2008 Feb; 70(6):414-5. PubMed ID: 18250286
[No Abstract] [Full Text] [Related]
9. Quantitative analysis of clonal bone marrow CD19+ B cells: use of B cell lineage trees to delineate their role in the pathogenesis of light chain amyloidosis.
Manske MK; Zuckerman NS; Timm MM; Maiden S; Edelman H; Shahaf G; Barak M; Dispenzieri A; Gertz MA; Mehr R; Abraham RS
Clin Immunol; 2006 Jul; 120(1):106-20. PubMed ID: 16515886
[TBL] [Abstract][Full Text] [Related]
10. Morphologic and quantitative assessment of CD20+ B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumonia.
Atkins SR; Turesson C; Myers JL; Tazelaar HD; Ryu JH; Matteson EL; Bongartz T
Arthritis Rheum; 2006 Feb; 54(2):635-41. PubMed ID: 16447242
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of Fas/Fas ligand in inclusion body myositis.
Fyhr IM; Oldfors A
Ann Neurol; 1998 Jan; 43(1):127-30. PubMed ID: 9450780
[TBL] [Abstract][Full Text] [Related]
12. Permissive environment for B-cell maturation in myositis muscle in the absence of B-cell follicles.
Salajegheh M; Pinkus JL; Amato AA; Morehouse C; Jallal B; Yao Y; Greenberg SA
Muscle Nerve; 2010 Oct; 42(4):576-83. PubMed ID: 20740627
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
Arahata K; Engel AG
Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory myopathies: evaluation and management.
Greenberg SA
Semin Neurol; 2008 Apr; 28(2):241-9. PubMed ID: 18351525
[TBL] [Abstract][Full Text] [Related]
15. B-lymphocyte and plasma cell clonal expansion in monosymptomatic optic neuritis cerebrospinal fluid.
Haubold K; Owens GP; Kaur P; Ritchie AM; Gilden DH; Bennett JL
Ann Neurol; 2004 Jul; 56(1):97-107. PubMed ID: 15236406
[TBL] [Abstract][Full Text] [Related]
16. Muscle lymphocytic infiltrates in thymoma-associated myasthenia gravis are phenotypically different from those in polymyositis.
Zamecnik J; Vesely D; Jakubicka B; Simkova L; Pitha J; Schutzner J; Mazanec R; Vogel H
Neuromuscul Disord; 2007 Dec; 17(11-12):935-42. PubMed ID: 17651972
[TBL] [Abstract][Full Text] [Related]
17. Inclusion body myositis: clinical and pathological boundaries.
Amato AA; Gronseth GS; Jackson CE; Wolfe GI; Katz JS; Bryan WW; Barohn RJ
Ann Neurol; 1996 Oct; 40(4):581-6. PubMed ID: 8871577
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory muscle diseases: a critical review on pathogenesis and therapies.
Dalakas MC
Curr Opin Pharmacol; 2010 Jun; 10(3):346-52. PubMed ID: 20409756
[TBL] [Abstract][Full Text] [Related]
19. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.
Barbasso Helmers S; Dastmalchi M; Alexanderson H; Nennesmo I; Esbjörnsson M; Lindvall B; Lundberg IE
Ann Rheum Dis; 2007 Oct; 66(10):1276-83. PubMed ID: 17277004
[TBL] [Abstract][Full Text] [Related]
20. Evidence for heterogeneity of T cell expansion in polymyositis and inclusion body myositis.
van der Meulen MF; van Wichen DF; van Blokland WT; van den Berg LH; Wokke JH; Hoogendijk JE; de Weger RA
J Neuroimmunol; 2002 Dec; 133(1-2):198-204. PubMed ID: 12446023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
